Aims: The aim of this study was to investigate the quality and timing of the diagnosis and treatment of nocturia in real-life practice in European and US-American patients to obtain better insights into the management of nocturia in different Western healthcare systems.
| BACKGROUND AND OBJECTIVES
Lower urinary tract symptoms (LUTS) affect a large proportion of the adult female and male population worldwide but are often underreported due to embarrassment, acceptance of LUTS as an inevitable part of ageing, or lack of knowledge about the condition. [1] [2] [3] [4] LUTS are unspecific for age and gender and have a multifactorial aetiology. 5, 6 Early attempts to classify symptoms based around concepts of "prostatism" or benign prostatic hyperplasia (BPH) in men and overactive bladder (OAB) in women have long been recognised to be inadequate. [7] [8] [9] Neither OAB nor BPH produces a consistent set of symptoms in all patients. 10 As LUTS can be highly bothersome and patients seek help for fast symptom relief, 11, 12 it is imperative that patients are assessed, labelled and treated correctly at the physician office.
One symptom in particular, nocturia, seems to be consistently overlooked in clinical practice with regard to its specific aetiology, impact on
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quality-of-life and treatment, despite its high prevalence. 13 The analysis 15 Of all individual symptoms, nocturia had the highest symptom bother and was the only symptom significantly associated with physician consultations during the previous 2 years. 16 Key instruments for diagnosing, quantifying and discriminating LUTS, with or without urinary incontinence, are patient history, symptom questionnaires and bladder diaries. 17, 18 However, only bladder diaries can objectively quantify the number of voids during day-and night-time as well as document drinking and micturition volumes.
Bladder diaries should be taken for 2-7 days and are recommended by international guidelines in patients with bladder storage symptoms or nocturia. [19] [20] [21] Without a bladder diary, it may be difficult to ascertain the correct diagnosis and, hence, the best possible treatment option(s).
Despite the recognition of nocturia by the International Continence
Society and publication of a standardisation report, nocturia may be different and independent from other LUTS. 22 During the last decade, nocturia has gained increasing interest in the literature but it remains to be determined whether this has also translated into a greater focus in clinical practice with regard to earlier diagnosis or specific treatment.
The aim of this study was to investigate the quality and timing of the diagnosis and treatment of nocturia by means of a large database analysis of European and US-American patients to obtain better insights into the management of nocturia in different Western healthcare systems. Portability and Accountability Act 1996 23 and as such ethical approval was not required. Informed consent was obtained after physicians explained the study and patients reviewed the collection forms. Data were collected by local fieldwork partners and were fully anonymised.
| MATERIAL AND METHODS

Data
Physicians were reimbursed for their participation in the study by the What's known
• Lower urinary tract symptoms (LUTS) and nocturia are highly prevalent in adult men and women in Western Societies.
• Lower urinary tract symptoms are disease-and genderunspecific and highly bothersome, decrease quality-oflife and are responsible for morbidity/mortality.
• Bladder diaries can assess and quantify LUTS, can differentiate between the various causes, and are recommended by guidelines.
• Drug treatment should target the underlying pathophysiology of LUTS and nocturia.
What's new
• Clarifies the amount of patients seeking help for LUTS and/or nocturia in five Western countries.
• Describes the time between symptom onset and first consultation, diagnosis and treatment.
• Determines the reasons for physician consultations.
• Evaluates assessment tools and the use of bladder diaries.
• Describes the treatment pattern according to the type of LUTS.
• Quantifies conservative and medical treatment of LUTS and/or nocturia.
T A B L E 1 Patient demographics and number of day-and night-time voids reported by physicians or patients; numbers are provided as mean±SD or in %, range in parentheses local fieldwork partners at fair market rates and the fieldwork teams adhered to national data collection regulations. A full description of the methodology has been published previously.
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Based on the clinical diagnoses of the physicians, patients were divided into one of the six groups:
• men with nocturia only
• men with BPH or OAB only
• men with nocturia+BPH or OAB
• women with nocturia only
• women with OAB only
• women with nocturia+OAB.
Demographic data, patient-and physician-reported number of voids (during day and night), reasons for consulting a medical professional, type of medical physician visited, use of a bladder diary, time to consultation, diagnosis and treatment and type of treatment were recorded and evaluated in this study.
| RESULTS
| Patient demographics and number of voids
A total of 627 physicians [261 PCPs (41.6%) and 366 urologists or gynaecologists (58.4%)] completed records for 8738 patients, of whom 5335 (61.1%) completed the PSC. A diagnosis was reported by physicians in 8659 cases (99.1%). Of the total patient population with a diagnosis label, the mean age was 64.0 years and 5165 participants (59.6%) were men ( Table 1 and Fig. 1 ). The "average" patient was slightly overweight. The majority of patients (71%) lived with a partner and was not employed (68%), with the majority of these being retired.
Eighty-five per cent of patients had comorbid conditions of which arterial hypertension (46%), hyperlipidaemia (26%) and diabetes mellitus (19%) were most frequently reported (Table 1) .
Patients reported a mean of 7.5 daytime and 2.5 night-time voids.
Physicians appeared to under-record the number of daytime voids compared with patient reports in all male and female patient subgroups but were more likely to agree with the patient on the number of nocturnal voids. A total of 2244 patients (25.9%) had a confirmed diagnosis of nocturia (nocturia or nocturnal polyuria; Table 1 and Fig. 1 
| Reasons for consulting medical professionals
The majority of patients (69%) first consulted a PCP, of whom 
| Use of bladder diaries
Only 37% of all LUTS diagnoses were based on previous bladder diaries. Among men diagnosed with "nocturia+BPH/OAB," only 35% had completed a diary before participating in the LUTS-DSP. A greater proportion of females with "nocturia+OAB" had previously completed a diary (55%). Men with "BPH or OAB only" were the least likely group to have been diagnosed with a bladder diary (27%). In the subgroup of patients with nocturia of any type (Table 2) , PCPs were particularly unlikely to have employed a bladder diary to make the diagnosis of nocturia and differentiate the underlying pathophysiology (34%).
Among specialists, urologists had employed a bladder diary to evaluate nocturia in 45% of patients, whereas gynaecologists were the most likely physician group to have used a bladder diary for diagnosis (60%).
In patient groups without nocturia as part of the diagnosis, 40%
of the patients with at least one nocturnal void, who felt bothered by nocturnal voiding, were diagnosed using a bladder diary. This number was even lower in patients with ≥2 voids per night (37%). Even among patients diagnosed with nocturnal polyuria, 45% of the patients were diagnosed without a diary. Approximately half of the female patients with nocturia (48%) were not evaluated with a diary, while this proportion increased to 63% in men.
| Time to treatment
Overall, patients took approximately one year to consult a medical professional following the onset of LUTS (Table 3) Men and women with a mixed nocturia diagnosis waited for a mean of 105 weeks from symptom onset to first treatment, while those with a "nocturia only" diagnosis had a slightly shorter time to treatment (mean for men 93 weeks vs women 92 weeks; difference ~12 weeks).
| Initial treatment
During the initial office visit to any type of medical professional, most patients were given advice on behavioural strategies, such as limitation of fluid intake, avoidance of alcohol or caffeine, and bladder training, but almost a quarter (23%) of patients were not currently receiving any lifestyle advice or behavioural modifications (Table 4) .
Women with nocturia, with or without OAB, were most likely to receive conservative treatments, most frequently pelvic floor muscle exercise or bladder training.
Most patients were on drug treatment (Fig. 3) . In the "nocturia only" group, 19% of men and 22% of women were not receiving prescription drugs for their LUTS condition (although they may have received behavioural advice) at the time of the survey -the highest proportion of any diagnosis group. In the group of men with "nocturia+BPH/OAB," only 6% were not receiving prescription drugs for their LUTS condition.
Regardless of the type of physician currently consulted and pres- 
| DISCUSSION
This study included 8659 adult male and female patients who sought help for LUTS by a physician during a 4-month data collection pe- night were bothered by nocturia, they were not particularly labelled with the diagnosis "nocturia;" instead, nocturia in these patients was considered to be a part of the diagnosis "BPH" or "OAB."
Timing of first consultation after appearance of LUTS (nocturia)
as well as evaluation of the time from the assessment to initiation of LUTS (nocturia) treatment has never been described before. Therefore, this observational study, for the first time, provides valuable information accordingly. The time from first symptom appearance to first physician consultation was almost 1 year for all patient subgroups but the time for patients with nocturia appeared to be slightly shorter, suggesting a clinically important increase in bother associated with this symptom. The time from the diagnosis to the initiation of first therapy, behavioural treatment and lifestyle advice included, was surprisingly long, ranging from 27 to 41 weeks. Furthermore, the total time from first symptom appearance to first prescribed treatment was approximately 2 years, which also seems surprisingly long and underlines that LUTS are often considered an unescapable part of ageing by patients and suggests that physicians may underestimate the symptom burden, bother and decrease in quality-of-life associated with LUTS.
Only 37% of the LUTS patients were diagnosed and their symptoms differentiated with a bladder dairy. Of these, 75% of patients (n=1401) had ≥2 voids per night, but were not specifically diagnosed with nocturia. Among the 63% of patients with LUTS who were diagnosed without a bladder diary, 70% of patients (n=2207) had ≥2 voids per night, yet were not labelled with the diagnosis "nocturia." It has to be kept in mind that several community-based studies determined a night-time frequency ≥2 voids to be associated with substantial symptom bother and decrease in health-specific quality-of life. 16, 25 Furthermore, two longitudinal population studies demonstrated that a night-time frequency ≥2 voids is associated with a significantly T A B L E 2 Proportion of patients with any type of nocturia previously completing a bladder diary All patients with ≥1 nocturnal void+bother (without a diagnosis of nocturia) 1212 40
All patients with ≥2 nocturnal voids (without a diagnosis of nocturia) 2433 37
First consulted due to tiredness (without a diagnosis of nocturia) 286 35
Diagnosis of nocturnal polyuria by physician 589 55
Percentages were calculated excluding missing responses.
a For patients with a diagnosis of nocturia (nocturia or nocturnal polyuria).
increased mortality rate during the next 5 years. 26, 27 This leads to the questions why so few physicians used bladder diaries and, when a bladder diary was used, why the physicians did not transfer the diary results to meaningful, pathophysiology-based treatments, especially considering that bladder diaries are recommended by several expert groups and guideline panels in case patients report about nocturia or bladder storage symptoms. 17, 20, 21 A bladder diary for 2-7 days is the diagnostic tool of first choice to detect the underlying pathophysiology of nocturia, where global polyuria (24-hour urine volume >40 mL/ kg body weight), nocturnal polyuria (nocturnal urine volume >33% of the 24-hour urine volume) or reduced maximum voided volume (urinary frequency due to reduced anatomical or functional bladder capacity) can be discriminated. 22, 28 The results of bladder diaries can be Bladder diaries were more likely to be used when the diagnosis "nocturnal polyuria" rather than "nocturia" was part of the symptom complex. However, even within the group of patients with a diagnosis of "nocturnal polyuria," the diagnosis was based on a bladder diary in only 55% of the cases. More reassuring was the finding that attempts nocturnal polyuria with this drug also in the elderly population but without the risk of hyponatremia. Combined with a low use of bladder diaries, and long-time interval from initial visit to the doctor to medical treatment of symptoms, it seems that treatment of LUTS patients can still be optimised.
| LIMITATIONS
Limitations of the observational research and real world data collection approach used in the LUTS-DSP include selection and diagnosis of patients. Although respondents are requested to collect data on a series of consecutive patients to avoid selection bias, in the absence of randomisation this is contingent upon the integrity of the participating respondent rather than formalised source verification procedures.
Moreover, diagnosis in the target patient group is based primarily on the judgement and diagnostic skills of the respondent physician rather than on a formalised diagnostic checklist, although patients are managed in accordance with the same routine diagnostic procedures representative of that clinical practice setting. A further limitation of the DSPs is that being cross-sectional, they cannot be used to demonstrate cause and effect. To demonstrate this, an experimental study would be necessary -even analyses of large administrative databases do not allow for causal inferences to be made due to their design and the need for statistical control of confounding factors.
These limitations need to be balanced against the methodological strengths that ensure the representative nature of the respondent sample within predefined parameters. Moreover, the methodology takes into account the potential differences in customs and practices for the management of target illnesses across different cultures and countries. Protocol/project development, data analysis, drafting, critical revision and approval of article.
